Literature DB >> 8327496

Interleukin 1 signaling occurs exclusively via the type I receptor.

J E Sims1, M A Gayle, J L Slack, M R Alderson, T A Bird, J G Giri, F Colotta, F Re, A Mantovani, K Shanebeck.   

Abstract

Two receptors for the proinflammatory cytokine interleukin 1 (IL-1) have been cloned and characterized biochemically. While it has been well established that the type I (80-kDa) IL-1 receptor can mediate responses to IL-1, the function of the type II (60-kDa) IL-1 receptor has been unknown. In this manuscript we describe experiments designed to ask whether the type II receptor is capable of delivering a biological signal. We have examined two types of experimental situation: responses to IL-1 in cells which express predominantly the type II receptor, and responses to IL-1 which have been suggested previously in the literature to be mediated by type II receptors. In both situations we find that the responses instead are mediated via type I receptors. A blocking antibody against the type II receptor never inhibits, and in fact sometimes enhances, the responses. We conclude that a very small number of type I receptors is sufficient to mediate all of the actions of IL-1 which we have examined here and that the function of the type II receptor may not be to transduce signals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8327496      PMCID: PMC46886          DOI: 10.1073/pnas.90.13.6155

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  A biochemical and kinetic analysis of the interleukin-1 receptor. Evidence for differences in molecular properties of IL-1 receptors.

Authors:  R Horuk; J J Huang; M Covington; R C Newton
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

2.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

3.  Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.

Authors:  F Colotta; G Peri; A Villa; A Mantovani
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

4.  Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein.

Authors:  M K Spriggs; D E Hruby; C R Maliszewski; D J Pickup; J E Sims; R M Buller; J VanSlyke
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

5.  Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells.

Authors:  J G Giri; P W Kincade; S B Mizel
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

6.  A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.

Authors:  A Alcamí; G L Smith
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

7.  Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line.

Authors:  S K Dower; S M Call; S Gillis; D L Urdal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors.

Authors:  J Slack; C J McMahan; S Waugh; K Schooley; M K Spriggs; J E Sims; S K Dower
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

9.  The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical.

Authors:  S K Dower; S R Kronheim; T P Hopp; M Cantrell; M Deeley; S Gillis; C S Henney; D L Urdal
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

10.  Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.

Authors:  S K Dower; S R Kronheim; C J March; P J Conlon; T P Hopp; S Gillis; D L Urdal
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  99 in total

1.  Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts.

Authors:  Yasushi Kawaguchi; Emi Nishimagi; Akiko Tochimoto; Manabu Kawamoto; Yasuhiro Katsumata; Makoto Soejima; Tokiko Kanno; Naoyuki Kamatani; Masako Hara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

Review 2.  Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?

Authors:  Wilma J Friedman
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

Review 3.  Regulation of neutrophil functions by proinflammatory cytokines.

Authors:  Takayuki Kato; Seiichi Kitagawa
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

4.  Regulation of IL-1 signaling through control of focal adhesion assembly.

Authors:  Qin Wang; Julie Delcorde; Tracy Tang; Gregory P Downey; Christopher A McCulloch
Journal:  FASEB J       Date:  2018-01-22       Impact factor: 5.191

5.  Regulation of brain interleukin-1 beta (IL-1 beta) system mRNAs in response to pathophysiological concentrations of IL-1 beta in the cerebrospinal fluid.

Authors:  S E Ilyin; G Sonti; D Gayle; C R Plata-Salamán
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

6.  Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.

Authors:  J A Symons; P R Young; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.

Authors:  T G Gleason; C W Houlgrave; A K May; T D Crabtree; R G Sawyer; W Denham; J G Norman; T L Pruett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Biologic and therapeutic significance of MYB expression in human melanoma.

Authors:  N Hijiya; J Zhang; M Z Ratajczak; J A Kant; K DeRiel; M Herlyn; G Zon; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Central interleukin-1 beta stimulation of vasopressin release into the rat brain: activation of an antipyretic pathway.

Authors:  M F Wilkinson; T F Horn; N W Kasting; Q J Pittman
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

Review 10.  The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain?

Authors:  Herve Boutin; Ian Kimber; Nancy J Rothwell; Emmanuel Pinteaux
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.